Underestimation of mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel

International Journal of Epidemiology

Volumn 29, Issue 2, 2000, Pages 369-375

  García García, Ma De Lourdes ^a   Valdespino Gómez, Jose Luis ^a   García Sancho, Cecilia ^a   Mayar Maya, Ma Eugenia ^a   Palacios Martínez, Manuel ^a   Balandrano Campos, Susana ^b   Escobar Gutiérrez, Alejandro ^b   Peruga, Armando ^a,c   Weissenbacher, Mercedes ^a,d   Daniels, Elaine ^a,e  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d UNAIDS   (Mexico)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anergy; BCG vaccine; CD4 lymphocytes; Delayed type hypersensitivity; HIV; Tuberculin test

Indexed keywords

BCG VACCINE; CANDIDA ANTIGEN; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; TETANUS TOXOID; TUBERCULIN;

ADULT; AGE; ARTICLE; BCG VACCINATION; CLONAL ANERGY; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEXICO; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SCAR FORMATION; SCREENING TEST; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, BACTERIAL; BCG VACCINE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV ANTIBODIES; HIV-1; HUMANS; MALE; MEXICO; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 0343674499     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/29.2.369     Document Type: Article

References (38)

1. Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990;335:387-90.
2. Tapia R, Ruiz-C, Ferreira E. Epidemiología de la tuberculosis en México. In: Sada E, Sifuenles J (eds). Tuberculosis. México: McGraw-Hill Interamericana Editores, México, 1995, pp.761-88. (Ramiro HM, Saita OK, eds. Temas de Medicina Interna; vol. 3.)
3. Tapia R, Ruiz-C, Ferreira E. Epidemiología de la tuberculosis en México. In: Sada E, Sifuenles J (eds). Tuberculosis. México: McGraw-Hill Interamericana Editores, México, 1995, pp.761-88. (Ramiro HM, Saita OK, eds. Temas de Medicina Interna; vol. 3.)
4. Mexican Ministry of Health. Report of the National Program for Prevention and Control of Tuberculosis, 1997.
5. Valdespino JL, Velasco O, Escobar A (eds). Enfermedades Tropicales en México. Diagnóstico, tratamimto y distribución geográfica. México: Secretaría de Salud, 1994, pp.215-25.
6. Valdespino JL, García ML, Del Río A, Loo E, Magis C, Salcedo RA. Epidemiologia del SIDA-VIH en México; de 1983 a marzo de 1995. Salud Pública Méx 1995;37:556-71.
7. García ML, Valdespino JL, García Sancho C, Salcedo R, Zacarías F, Sepúlveda J. Epidemiology of AIDS and tuberculosis. PAHO Bull 1995;29:37-59.
8. Cano DC, Villarreal UC, Gómez CG et al. La importancia de la tuberculosis en el sindrome de inmunodeficiencia adquirida. Gac Méd de Méx 1991;127:137-41.
9. Molina Gamboa J, Ponce de Leon S, Sifuentes Osornio J, Bobadilla del Valle M, Ruiz Palacios G. Mycobacterial infection in Mexican AIDS patients. J Acquir Immune Defic Syndr Hum Retro 1996;11:53-58.
10. Romo J, Salido F. The difficult diagnosis of tuberculosis in AIDS patients. Eighth International Conference on AIDS/in affiliation with the Third STD World Congress, Amsterdam, 19-24 July 1992, Abstr MBP:374.
11. Jessurun J, Angeles Angeles A, Gasman N. Comparative demographic and autopsy findings in acquired immunodeficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndr 1990;3:579-83.
12. Mohar A, Romo J, Salido F et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 1992;6:467-73.
13. García ML, Valdespino JL, Palacios M, Mayar ME, García Sancho C, Sepúlveda J. Tuberculosis y SIDA en México. Salud Pública Méx 1995;37:539-48.
14. Centers for Disease Control. Screening for tuberculosis and tuberculosis infection in high risk populations: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990;39(RR-8):1-12.
15. Anonymous. Tuberculosis preventive therapy in HIV-infected individuals: a joint statement of the International Union against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO). Tuber Lung Dis 1994;75:96-98.
16. Ponce de León S, Chiriboga C (eds). Guía para la atención médica de pacientes con infección par VIH/SIDA en consulta externa y hospitales. México: Secretaría de Salud, 1995, pp.43-44.
17. Secretaría de Salud. Norma Oficial Mexicana NOM-006-SSA2 1993, para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 1995 Jan 26, pp.20-29.
18. State Serum Institut. Tuberculin PPD RT 23 SSI. 20163-02. Denmark: Staten Serum Institut, 1997.
19. Instituto Nacional de Diagnóstico y Referencia Epidemiológicas. Manual de procedimientos para inmunología. México: Secretaría de Salud, 1994, pp.5-42.
20. Instituto Nacional de Diagnóstico y Referencia Epidemiológicas. Manual de procedimientos para micobacterias. México: Secretaría de Salud, DF, 1991.
21. Cárdenas V, Bernal J, Cabrera L et al. Encuestas tuberculínicas en Guerrero y nuevas estimaciones de la magnitud de la infección tuberculosa en México. Salud Pública Méx 1989;31:73-81.
22. Molina Gamboa J, Rivera-Morales I, Ponce de Leon S. Prevalence of tuberculin reactivity among health care workers from a Mexican hospital. Inf Control Hosp Epidem 1994;15:319-20.
23. Johnson MP, Coberly JS, Clermont HC et al. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J Infect Dis 1992;166:194-98.
24. Ferreira M, Satto MA, Campos A et al. HIV positivity and tuberculin skin test (PPD) among female inmates in Brazil. Ninth International Conference on AIDS in affiliation with the Fourth STD World Congress, Berlin, 6-11 June 1993, Abstr PO-B07-1252.
25. Okwera A, Erikki PP, Luay LA et al. Tuberculin reaction in apparently healthy HIV-seropositive and HIV-seronegative women - Uganda. MMWR 1990;39:638-46.
26. Consejo Nacional de Vacunacíon. Memoria 1990-1994. México: Secretaría de Salud, 1994, pp.51-59.
27. Amadottir T, Rieder HL, Trebucq A, Waaler HT. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis 1996;77 (Suppl 1):1-19.
28. Huebner RE, Villarino ME, Snider DE. Tuberculin skin testing and the HIV epidemic. JAMA 1992;267:409-10.
29. Graham NM, Nelson KE, Solomon L et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and seronegative intravenous drug users. JAMA 1992;267:369-73.
30. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991; 40(Suppl.RR-5):27-32.
31. Nash DR, Douglas JE. Anergy in active pulmonary tuberculosis. A comparison between positive and negative factors and an evaluation of 5 TU and 250 TU skin test doses. Chest 1980;77:32-37.
32. Centers for Disease Control. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998; 47(RR-20):36-41.
33. Felton CP, Ford JG. Tuberculosis in the inner city. In: Reichman LE, Hershfield ES (eds). Tuberculosis. New York: Marcel Dekker Inc., 1995, pp.483-503.
34. Espinal MA, Reingold AL, Koenig E, Lavandera M, Sanchez S. Screening for active tuberculosis in HIV testing centre. Lancet 1995; 345:890-93.
35. Miret-Cuadras P, Pina-Gutierrez JM, Juncosa S. Tuberculin reactivity in Bacillus Calmette Guerin vaccinated subjects. Tuber Lung Dis 1996; 77:52-58.
36. Joncas JH, Robitaille R, Gauthier T. Interpretation of the PPD skin test in BCG-vaccinated children. Can Med Assoc J 1975;113:127-28.
37. Markowitz N, Hansen N, Wilcsky T et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 1993;119:185-93.
38. PanAmerican Health Organization. Association between HIV and tuberculosis: technical guide: PAHO Bull 1993;27:297-310.